ClinicalTrials.Veeva

Find clinical trials for Heart Disease in Hanyang, Seoul

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Heart Diseases
Coronary Artery Disease
Cardiovascular Diseases
Myocardial Ischemia
Heart Failure
Coronary Disease
Hypertension

Heart Disease trials near Hanyang, Seoul, KOR:

Pulsta® Transcatheter Pulmonary Valve Korean Multicenter Study

The purpose of this study is to evaluate the safety and effectiveness of the TPV in patients with pulmonary valve dysfunction.

Active, not recruiting
Congenital Heart Defect
Pulmonary Valve; Insufficiency, Congenital
Device: Pulsta® Transcatheter Pulmonary Valve (TPV) Replacement
Taewoong Medical

Seoul, Haehak-ro Jongno-gu, Korea, Republic of and 4 other locations

The purpose of the study is to evaluate the safety and effectiveness of the PULSTA Transcatheter Pulmonary Valve (TPV) System for the treatment of co...

Active, not recruiting
Heart Diseases
Tetralogy of Fallot
Device: PULSTA TPV System
Taewoong Medical

Seoul, Haehak-ro Jongno-gu, Korea, Republic of and 10 other locations

The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Seoul, Korea, Republic of and 466 other locations

the safety and efficacy of drug-coated balloon (DCB) treatment compared to drug-eluting stenting (DES) in patients with large coronary artery disease...

Enrolling
Coronary Artery Disease
Myocardial Ischemia
Device: SeQuent® Please NEO drug-coated balloon catheter
Device: Current-generation drug-eluting stent
B. Braun
B. Braun

Seoul, Korea, Republic of and 14 other locations

reduction of cardiovascular death (generally meaning death due to disease of the heart or blood vessels) and total Heart F...

Active, not recruiting
Heart Failure
Other: Placebo
Drug: Finerenone (BAY94-8862)

Phase 3

Bayer
Bayer

Seoul, Korea, Republic of and 663 other locations

The aim of this study is to assess the level of glycemic control and the incidence of surgery-related complications in cardiac patients post-surgery...

Enrolling
Cardiac Disease
Diabetes Mellitus
Device: Dexcom G6
Device: SMBG or venous/arterial blood glucose
Kangbuk Samsung Hospital

Seoul, Korea, Republic of

Recently updated

software to assist clinicians in the diagnosis of coronary artery disease by predicting coronary artery stenosis (≥50%) from a multimodal AI...

Enrolling
Coronary Artery Disease
Diagnosis
Diagnostic Test: Assisted by the AI-Gatekeeper software group
INFINITT Healthcare

Seoul, Korea, Republic of and 4 other locations

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...

Active, not recruiting
Coronary Heart Disease (CHD)
Drug: Evolocumab
Drug: Placebo

Phase 3

Amgen
Amgen

Seoul, Korea, Republic of and 851 other locations

The primary objective of this study is to assess the efficacy of a single dose of ravulizumab IV compared with placebo in reducing the risk of the cl...

Enrolling
Chronic Kidney Disease
Cardiac Disease
Drug: Placebo
Drug: Ravulizumab

Phase 3

Alexion Pharmaceuticals
Alexion Pharmaceuticals

Seoul, Korea, Republic of and 159 other locations

would improve clinical and echocardiographic outcomes in heart failure (HF) patients with functional tricuspid regurgitation (TR) and preser...

Enrolling
Heart Failure With Preserved Ejection Fraction
Tricuspid Regurgitation
Drug: Enavogliflozin
Drug: Placebo

Phase 3

Asan Medical Center

Seoul, Korea, Republic of and 4 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems